« Previous Next » Leukemia Research
Volume 34, Issue 10 , Pages 1255-1268 , October 2010

BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review

Xin An
- Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, St. John's University, 8000 Utopia Parkway, Jamaica, NY 11439, USA
- Department of Medical Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, China
- State Key Laboratory of Oncology in South China, Sun Yat-Sen University, Guangzhou, China
- These authors contributed equally to this work.
Amit K. Tiwari
- Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, St. John's University, 8000 Utopia Parkway, Jamaica, NY 11439, USA
- These authors contributed equally to this work.
Yibo Sun
- Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, St. John's University, 8000 Utopia Parkway, Jamaica, NY 11439, USA
- These authors contributed equally to this work.
Pei-Rong Ding
- Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, St. John's University, 8000 Utopia Parkway, Jamaica, NY 11439, USA
- Department of Medical Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, China
- State Key Laboratory of Oncology in South China, Sun Yat-Sen University, Guangzhou, China
- These authors contributed equally to this work.
Charles R. Ashby Jr.
- Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, St. John's University, 8000 Utopia Parkway, Jamaica, NY 11439, USA
Zhe-Sheng Chen
- Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, St. John's University, 8000 Utopia Parkway, Jamaica, NY 11439, USA
- Corresponding author. Tel.: +1 718 990 1432; fax: +1 718 990 1877.